Fig. 6
From: LncRNA WEE2-AS1 is a diagnostic biomarker that predicts poor prognoses in patients with glioma
GSEA analysis results of the TCGA RNA-seq data
(A)–(E) The cell cycle mitotic (A), DNA repair (B), Fc epsilon receptor I (FCERI)-mediated nuclear factor kappa light chain enhancer of activated B cells (NF-κB) activation (C), cell surface interactions at the vascular wall (D), and GBM silenced by methylation (E) pathways were differentially enriched the in WEE2-AS1 high-expression phenotype. (F)–(I) In the WEE2-AS1 low-expression phenotype, enriched pathways included the neurotransmitter release cycle (F), mitogen-activated protein kinase (MAPK) signaling (G), Wnt signaling pathways (H) and calcium signaling pathways (I)